About AHEAD
Ahead (legally Abe Health LLC) was a US telehealth startup that diagnosed and treated adult ADHD by video, with salaried clinicians and 60-minute first visits. Its main investor, Truepill, had put about $9 million into the company before shifting to business-to-business services. Ahead stopped accepting new patients in mid-April 2022 and planned to end care for current patients by June 24, 2022. Its website, helloahead.com, now shows only a maintenance page.